0001209191-21-002418.txt : 20210106 0001209191-21-002418.hdr.sgml : 20210106 20210106211209 ACCESSION NUMBER: 0001209191-21-002418 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210104 FILED AS OF DATE: 20210106 DATE AS OF CHANGE: 20210106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Camardo Daniel A. CENTRAL INDEX KEY: 0001820365 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35238 FILM NUMBER: 21512740 MAIL ADDRESS: STREET 1: C/O HORIZON THERAPEUTICS, PLC STREET 2: CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD CITY: DUBLIN STATE: L2 ZIP: D04 C5Y6 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Horizon Therapeutics Public Ltd Co CENTRAL INDEX KEY: 0001492426 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 BUSINESS PHONE: 011-353-1-772-2100 MAIL ADDRESS: STREET 1: CONNAUGHT HOUSE, 1ST FLOOR STREET 2: 1 BURLINGTON ROAD CITY: DUBLIN STATE: L2 ZIP: 4 FORMER COMPANY: FORMER CONFORMED NAME: Horizon Pharma plc DATE OF NAME CHANGE: 20140919 FORMER COMPANY: FORMER CONFORMED NAME: HORIZON PHARMA, INC. DATE OF NAME CHANGE: 20100520 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-01-04 0 0001492426 Horizon Therapeutics Public Ltd Co HZNP 0001820365 Camardo Daniel A. C/O HORIZON THERAPEUTICS PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 4 IRELAND 0 1 0 0 EVP and President, U.S. Ordinary Shares 2021-01-05 4 M 0 20614 A 52513 D Ordinary Shares 2021-01-05 4 F 0 9230 73.28 D 43283 D Restricted Stock Units (RSU) 2021-01-04 4 A 0 20957 0.00 A Ordinary Shares 20957 20957 D Restricted Stock Units (RSU) 2021-01-05 4 M 0 5634 0.00 D 2021-01-05 2021-01-05 Ordinary Shares 5634 0 D Restricted Stock Units (RSU) 2021-01-05 4 M 0 10626 0.00 D Ordinary Shares 10626 10626 D Restricted Stock Units (RSU) 2021-01-05 4 M 0 4354 0.00 D Ordinary Shares 4354 8708 D Each RSU represents a contingent right to receive one ordinary share of the Issuer. Includes 1,070 ordinary shares of the Issuer acquired by the reporting person on December 1, 2020 pursuant to an employee stock purchase program. The RSU's vest 1/3rd annually on each anniversary of January 5, 2020. The RSU's vest 1/3rd annually on each anniversary of January 5, 2019. /s/ Miles W. McHugh, Attorney-in-Fact 2021-01-06